Chemical neurolysis for the conservative treatment of hip fractures.

IF 1.4 Q4 CLINICAL NEUROLOGY
Pain management Pub Date : 2024-06-02 Epub Date: 2024-06-28 DOI:10.1080/17581869.2024.2368453
Catarina C Duarte, João Galacho, Alexandra Resende, André Spranger, Mariano Veiga
{"title":"Chemical neurolysis for the conservative treatment of hip fractures.","authors":"Catarina C Duarte, João Galacho, Alexandra Resende, André Spranger, Mariano Veiga","doi":"10.1080/17581869.2024.2368453","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> Hip fracture management is challenging when surgical risks outweigh benefits. Inadequate analgesia from conservative treatments prompted new procedures targeting hip capsule denervation. This study evaluates the efficacy and safety of single injection chemical hip neurolysis in the pericapsular nerve group plane.<b>Materials & methods:</b> In eligible patients, an ultrasound-guided diagnostic block was performed using 5 ml of 2% lidocaine in the pericapsular nerve group plane. If positive, 6 ml of 99.9% alcohol was administered.<b>Results:</b> From May 2022 to May 2023, five patients underwent hip neurolysis. None reported pain at day 5 or during follow-up. There were no adverse effects.<b>Conclusion:</b> Chemical neurolysis seems to provide effective and safe conservative treatment for hip fractures, offering reliable analgesia for nonsurgical candidates.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11340735/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17581869.2024.2368453","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: Hip fracture management is challenging when surgical risks outweigh benefits. Inadequate analgesia from conservative treatments prompted new procedures targeting hip capsule denervation. This study evaluates the efficacy and safety of single injection chemical hip neurolysis in the pericapsular nerve group plane.Materials & methods: In eligible patients, an ultrasound-guided diagnostic block was performed using 5 ml of 2% lidocaine in the pericapsular nerve group plane. If positive, 6 ml of 99.9% alcohol was administered.Results: From May 2022 to May 2023, five patients underwent hip neurolysis. None reported pain at day 5 or during follow-up. There were no adverse effects.Conclusion: Chemical neurolysis seems to provide effective and safe conservative treatment for hip fractures, offering reliable analgesia for nonsurgical candidates.

化学神经溶解术用于髋部骨折的保守治疗。
目的:当手术风险大于手术收益时,髋部骨折的治疗具有挑战性。由于保守疗法的镇痛效果不佳,因此出现了针对髋关节囊神经支配的新疗法。本研究评估了在髋关节囊周围神经组平面进行单次注射化学髋关节神经松解术的有效性和安全性。材料和方法:在符合条件的患者中,使用 5 毫升 2% 利多卡因在囊周神经组平面进行超声引导诊断阻滞。如果阳性,则注射 6 毫升 99.9% 酒精。结果:从 2022 年 5 月到 2023 年 5 月,五名患者接受了髋关节神经切除术。在第 5 天或随访期间,没有人报告疼痛。无不良反应。结论化学神经溶解术似乎能为髋部骨折提供有效、安全的保守治疗,为非手术治疗者提供可靠的镇痛效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pain management
Pain management CLINICAL NEUROLOGY-
CiteScore
2.90
自引率
5.90%
发文量
62
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信